Literature DB >> 25837429

Changes in bone mineral density following long-term simultaneous pancreas-kidney transplantation.

Ana Rocha1, La Salete Martins2, Jorge Malheiro2, Jorge Dores3, Clara Santos4, Castro Henriques2.   

Abstract

The symptoms of chronic renal disease-related mineral and bone disease improve significantly in patients after successful simultaneous pancreas-kidney transplantation (SPKT); however, bone pathology is still present even after many post-transplant years. The aim of this study was to analyze the bone densitometry in different periods after SPKT. Three-point densitometry was performed with the dual-energy X-ray absorptiometry (DXA) technique. Serum levels of alkaline phosphatase (ALP), total serum calcium, phosphate and parathyroid hormone were analyzed as markers of mineral metabolism. The study population consisted of 48 patients (28 females, 20 males) with a mean age of 35 ± 6 years and mean 24 ± 6 years of prior diabetes. Mean period of maintenance dialysis was 36 ± 26 months. The median time from SPKT and DXA measurement was 0.53, 26.2 and 41.9 months, respectively. Based on the DXA technique, 35.4 % of patients were categorized as having osteoporosis at the lumbar spine and 39.6 % at the femoral neck. Patients with diagnosed osteoporosis had significantly higher levels of ALP (OR = 1.5; 95 % CI = 1.1-2.2; p < 0.05 at the lumbar spine; OR = 1.4; 95 % CI = 1.0-1.9; p < 0.05 at the femoral neck). In addition, subjects with lumbar osteoporosis were characterized by a significantly lower body mass index (BMI) (OR = 0.5; 95 % CI = 0.3-0.9; p < 0.05). In the long-term follow-up, BMD increased significantly at the lumbar spine (T-score -1.86 ± 1.07 to -1.08 ± 0.89) and femoral neck (T-score -2.12 ± 0.78 to -1.63 ± 0.65). A multivariate linear model identified a BMI increase as a significant factor associated with improvement in BMD. Results of our study led us to conclude that, according to three-point densitometry, BMD among patients with functioning kidney and pancreas grafts improved. Increased serum levels of ALP were significantly associated with a decrease in BMD, suggesting a higher risk of osteoporosis. BMI gain was predictive of BMD improvement.

Entities:  

Keywords:  Alkaline phosphatase; Body mass index; Bone mineral density; Osteoporosis; Simultaneous pancreas-kidney transplantation

Mesh:

Substances:

Year:  2015        PMID: 25837429     DOI: 10.1007/s00774-015-0657-3

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  27 in total

1.  Factors influencing vertebral bone density after renal transplantation.

Authors:  Y Kokado; S Takahara; N Ichimaru; K Toki; M Kyo; S Permpongkosol; Y Kojima; T Inoue; J D Wang; A Okuyama
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

2.  Loss of bone mineral density in renal transplantation recipients.

Authors:  A Unal; I Kocyigit; M H Sipahioglu; B Tokgoz; F Kavuncuoglu; O Oymak; C Utas
Journal:  Transplant Proc       Date:  2010-11       Impact factor: 1.066

3.  Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the central and peripheral skeleton.

Authors:  Sapna P Iyer; Lucas E Nikkel; Kyle K Nishiyama; Elzbieta Dworakowski; Serge Cremers; Chiyuan Zhang; Donald J McMahon; Stephanie Boutroy; X Sherry Liu; Lloyd E Ratner; David J Cohen; X Edward Guo; Elizabeth Shane; Thomas L Nickolas
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

Review 4.  Management of mineral and bone disorder after kidney transplantation.

Authors:  Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy; Istvan Mucsi; Suphamai Bunnapradist
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

5.  The contribution of cortical and trabecular tissues to bone strength: insights from denosumab studies.

Authors:  Giovanni Iolascon; Rosa Napolano; Margherita Gioia; Antimo Moretti; Ilaria Riccio; Francesca Gimigliano
Journal:  Clin Cases Miner Bone Metab       Date:  2013-01

6.  Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.

Authors:  Jean-Paul Casez; Kurt Lippuner; Fritz F Horber; André Montandon; Philippe Jaeger
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

7.  Associations between serum bone-specific alkaline phosphatase activity, biochemical parameters, and functional polymorphisms of the tissue-nonspecific alkaline phosphatase gene in a Japanese population.

Authors:  Natsuko Sogabe; Rieko Tanabe; Mayu Haraikawa; Yutaka Maruoka; Hideo Orimo; Takayuki Hosoi; Masae Goseki-Sone
Journal:  Asia Pac J Clin Nutr       Date:  2013       Impact factor: 1.662

8.  Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.

Authors:  Mathias Haarhaus; Anders Fernström; Martin Magnusson; Per Magnusson
Journal:  Nephrol Dial Transplant       Date:  2009-06-19       Impact factor: 5.992

9.  Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.

Authors:  Sacide Atalay; Abdullah Elci; Huseyin Kayadibi; Can B Onder; Nurettin Aka
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

10.  Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX).

Authors:  S Fujiwara; T Nakamura; H Orimo; T Hosoi; I Gorai; A Oden; H Johansson; J A Kanis
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

View more
  3 in total

Review 1.  Osteoporosis in patients with diabetes after kidney transplantation.

Authors:  Elvira O Gosmanova; Aidar R Gosmanov
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 2.  Diabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation.

Authors:  Marcio W Lauria; Antonio Ribeiro-Oliveira
Journal:  Clin Diabetes Endocrinol       Date:  2016-07-15

3.  Osteoporosis Therapy With Denosumab in Organ Transplant Recipients.

Authors:  Jana Brunova; Simona Kratochvilova; Jitka Stepankova
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-17       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.